Cited by 37Hormonal and reproductive studiesGrowth Hormone and Insulin-like Growth FactorsNutrition and Health in Aging

Value of measuring muscle performance to assess changes in lean mass with testosterone and growth hormone supplementation

Open access
Schroeder, E. Todd, He, Jiaxiu, Yarasheski, Kevin E., Binder, Ellen F., Castaneda-Sceppa, Carmen, Bhasin, Shalender, Dieli-Conwright, Christina M., Kawakubo, Miwa +3 more·2012·European Journal of Applied Physiology

Abstract

We hypothesized that treatment with testosterone (T) and recombinant human growth hormone (rhGH) would increase lean mass (LM) and muscle strength proportionally and an in a linear manner over 16 weeks. This was a multicenter, randomized, controlled, double-masked investigation of T and rhGH supplementation in older (71 ± 4 years) community-dwelling men. Participants received transdermal T at either 5 or 10 g/day as well as rhGH at 0, 3.0 or 5.0 μg/kg/day for 16 weeks. Body composition was determined by dual-energy X-ray absorptiometry (DEXA) and muscle performance by composite one-repetition maximum (1-RM) strength and strength per unit of lean mass (muscle quality, MQ) for five major muscle groups (upper and lower body) at baseline, week 8 and 17. The average change in total LM at study week 8 compared with baseline was 1.50 ± 1.54 kg (P < 0.0001) in the T only group and 2.64 ± 1.7 (P < 0.0001) in the T + rhGH group and at week 17 was 1.46 ± 1.48 kg (P < 0.0001) in the T only group and 2.14 ± 1.96 kg (P < 0.0001) in the T + rhGH group. 1-RM strength improved modestly in both groups combined (12.0 ± 23.9%, P < 0.0001) at week 8 but at week 17 these changes were twofold greater (24.7 ± 31.0%, P < 0.0001). MQ did not significantly change from baseline to week 8 but increased for the entire cohort, T only, and T + rhGH groups by week 17 (P < 0.001). Despite sizeable increases in LM measurements at week 8, tests of muscle performance did not show substantive improvements at this time point.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00421-011-2077-y

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Improvements in lean mass do not directly result in improved function after testosterone therapy.

    “Improvements in lean mass do not directly result in improved function after testosterone therapy409.”

    From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [409]

    The Discussion reports that large lean-mass gains at week 8 were not accompanied by large improvements in muscle function, supporting the point that the gains did not immediately translate into functional improvement. But it also reports more substantial strength and muscle-performance gains by week 17, so the claim is too broad without a timing qualifier. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • In select older men over 60 years with testosterone deficiency and frailty, body composition and quality of life improved after testosterone supplementation.

    “In select older men over the age of 60 years with testosterone deficiency and frailty, body composition and quality of life improved following supplementation with testosterone409–411.”

    From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [409]

    The Results (‘Changes in body composition’; page not provided) report increased lean mass in older men receiving testosterone, supporting the body-composition portion. The Methods (‘Study participants’; page not provided) specify men aged 65–90 with testosterone in the lower portion of the adult range, but do not establish that they were frail or testosterone-deficient. The paper does not report an improvement in quality of life. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Despite significant increases in lean mass after testosterone and GH treatment, tests of muscle performance do not necessarily show substantial improvements after 8 weeks.

    “However, despite significant increases in lean mass after treatment with testosterone and GH, tests of muscle performance do not necessarily show substantial improvements after 8 weeks.88”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 39 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Schroeder, E. T., He, J., Yarasheski, K. E., Binder, E. F., Castaneda-Sceppa, C., Bhasin, S., Dieli-Conwright, C. M., Kawakubo, M., Roubenoff, R., Azen, S. P., & Sattler, F. R.
Affiliations
  • University of Southern California (US)
  • Washington University in St. Louis (US)
  • Boston University (US)
  • Tufts University (US)
Corresponding author
Schroeder, E. Todd
Venue
European Journal of Applied Physiology
Published
2011-07-12
Volume
112
Issue
3
Pages
1123-1131
ISSN
  • 0020-9376 (ISSN-L)
  • 1439-6319
  • 1439-6327
OpenAlex
W2024861227
Cited by
37
References
39
Citations by year
2026: 2 · 2025: 4 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 4 · 2016: 3 · 2015: 3 · 2014: 6 · 2013: 3 · 2012: 2
FWCI
2.88
Type
journal article
Language
en
Open access
Locations
  • European Journal of Applied Physiology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • U.S. Department of Agriculture
  • School of Medicine, Boston University
  • Deutsches Krebsforschungszentrum
  • National Institutes of Health (5p60dk020579-35, 5p41rr000954-34)
  • National Institute on Aging (U01AG014369, U01 AG14369, R01 AG18169, R01AG018169)
  • National Institute of General Medical Sciences (P41GM103422)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK 056341, R01DK070534, R01DK049393, 1R01DK70534, DK‐020579, P60-DK-020579, P30DK056341, P30DK020579)
  • National Center for Research Resources (P41-RR000954, M0I RR000043, RR-000954, M01RR000054, M01RR000043, M01RR000036)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Physiology › Nutrition and Health in Aging
Keywords
testosterone supplementation, recombinant human growth hormone, lean body mass, muscle performance, muscle strength, muscle quality, one-repetition maximum, older men, transdermal testosterone, body composition
MeSH terms
Aged, Body Composition, Double-Blind Method, Humans, Male, Predictive Value of Tests, Testosterone, Thinness, Geriatric Assessment, Muscle, Skeletal, Human Growth Hormone, Muscle Strength, Athletic Performance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review